{
    "content": "78 year-old lady referred for SABR assessment\n\nDiagnosis:\nT1bN0M0 squamous cell carcinoma left lower lobe. PD-L1 <1%\n\nProposed treatment:\nStereotactic ablative body radiotherapy (55Gy in 5 fractions)\n\nPET-CT 15.03.25: 18mm LLL peripheral nodule, SUV 8.2\nPFTs: FEV1 1.9L (85%), TLCO 72%\nCT guided biopsy confirmed moderately differentiated squamous cell carcinoma\n\nPast Medical History:\nParoxysmal AF on anticoagulation\nCOPD with previous exacerbation 2023\nOsteoarthritis both knees\nNo previous thoracic radiotherapy\nNo pacemaker/defibrillator\n\nDrug History:\nEdoxaban 60mg od\nFluticasone/vilanterol inhaler\nPantoprazole 40mg od\nParacetamol prn\nAllergy to penicillin (rash)\n\nSocial history:\nLives with husband\nMobility limited by arthritis\nEx-smoker 40 pack years, stopped 2015\nMinimal alcohol\nRetired postal worker\n\nCurrent status:\nMobile with walking stick\nExercise tolerance 100m on flat\nMild occasional cough\nNo haemoptysis\nWeight stable\n\nExamination:\nPS 1-2\nMild wheeze right base\nRegular rhythm\nNo peripheral edema\n\nDiscussion:\nExplained diagnosis of early stage lung cancer\nOutlined role of SABR with curative intent\nDetailed discussion of procedure, immobilization requirements, and potential side effects including fatigue, chest wall pain, and small risk of radiation pneumonitis\nPatient demonstrates good understanding and wishes to proceed\nConsent obtained\n\nPlan:\nTo proceed with SABR 55Gy in 5 fractions\nBooking for planning CT next week\nProvided emergency contact details\nFollow-up arranged for 3 months post treatment",
    "output": {
        "primary_cancer": {
            "site": "lung, left lower lobe",
            "year": 2025,
            "month": 3,
            "tnm_stage": "T1bN0M0",
            "histopathology_status": "moderately differentiated squamous cell carcinoma",
            "biomarker_status": "PD-L1 <1%",
            "cancer_timeline": [
                {
                    "type": "anatomical_finding",
                    "value": "PET-CT shows 18mm LLL peripheral nodule, SUV 8.2",
                    "year": 2025,
                    "month": 3
                },
                {
                    "type": "laboratory_finding",
                    "value": "CT guided biopsy confirmed moderately differentiated squamous cell carcinoma",
                    "year": 2025,
                    "month": 3
                }
            ]
        },
        "patient_facts": [
            {
                "type": "performance_status",
                "value": "PS 1-2"
            },
            {
                "type": "current_symptom",
                "value": "mild occasional cough"
            },
            {
                "type": "current_symptom",
                "value": "exercise tolerance 100m on flat"
            },
            {
                "type": "examination_finding",
                "value": "mild wheeze right base"
            },
            {
                "type": "examination_finding",
                "value": "regular rhythm"
            },
            {
                "type": "investigation_finding",
                "value": "PFTs: FEV1 1.9L (85%), TLCO 72%"
            },
            {
                "type": "comorbidity",
                "value": "Paroxysmal AF on anticoagulation"
            },
            {
                "type": "comorbidity",
                "value": "COPD with previous exacerbation 2023"
            },
            {
                "type": "comorbidity",
                "value": "Osteoarthritis both knees"
            }
        ],
        "status_updates": [
            {
                "type": "clinical_summary",
                "value": "Early stage left lower lobe lung cancer suitable for curative SABR, presenting with good performance status despite comorbidities including COPD and AF"
            },
            {
                "type": "update_to_treatment",
                "value": "To proceed with SABR 55Gy in 5 fractions"
            },
            {
                "type": "planned_investigation",
                "value": "Booking for planning CT next week"
            },
            {
                "type": "follow_up_referral",
                "value": "Follow-up arranged for 3 months post treatment"
            }
        ]
    }
}